Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2012

Dec 7, 2012

34117_dirs_2012-12-07_497fed3f-6974-415c-8a17-ec69ad465453.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-11-30

Reporting Person: KUMAR AMIT (Director)

Holdings (Non-Derivative)

Security Shares Ownership
CopyTele, Inc. common stock 59200 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Options (Right to Buy) $0.2175 2022-09-19 Common Stock (8000000) Direct
Employee Stock Options (Right to Buy) $0.2175 2022-09-19 Common Stock (8000000) Direct

Footnotes

F1: The option vests in 36 equal monthly installments beginning on 10/31/2012.

F2: The option becomes exercisable, if at all, as follows: (i) 2,666,666 shares upon the achievement of certain performance criteria; and (ii) 5,333,334 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels.